Pathogenesis of AIDS-related Kaposi's sarcoma

ONCOLOGY

Volumn 10, Issue 3, 1996, Pages 335-341

  Emmanoulides, Christos ^a   Miles, Steven A ^b   Mitsuyasu, Ronald T ^c,d  

^a Division of Hematology/Oncology

^b Department of Medicine ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; FEMALE; HOMOSEXUALITY; HUMAN; KAPOSI SARCOMA; MACROPHAGE; MALE; METABOLISM; PHYSIOLOGY; REVIEW; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CYTOKINES; FEMALE; HOMOSEXUALITY, MALE; HUMANS; MACROPHAGES; MALE; SARCOMA, KAPOSI;

EID: 0030091719     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Kaposi M. Idiopathic multiples Pigmentsarcom der Haut. Arch Dermatol Syph 4:265-274, 1872 (English translation, A Cancer Journal for Clinicians 32:342-347, 1982).
2. Kaposi M. Idiopathic multiples Pigmentsarcom der Haut. Arch Dermatol Syph 4:265-274, 1872 (English translation, A Cancer Journal for Clinicians 32:342-347, 1982).
3. Rabkin CS: Epidemiology of AIDS-related malignancies. Curr Opin Oncol 6.492-496, 1994.
4. Friedman-Kein A, Laubenstein L, Marmor M, et al: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men. Morbid Mortal Weekly Rep 30:305, 1981
5. Armenian HK, Hoover DR, Rubb S, et al: Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol 138:256-265, 1993.
6. Gallant JE, Moore RD, Richman DD, et al: Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudinc: Zidovudine epidemiology study group Arch Intern Med 154:566-572, 1994.
7. Friedman-Kien AE, Saltzman BR, Cao Y, et al: Kaposi's sarcoma in HIV negative homosexual men. Lancet 1:168-169, 1990.
8. Lassoued K, Clauvel JJ, Fegueux S, et al: AIDS-associated Kaposi's sarcoma in female patients. AIDS 5:877-880, 1991.
9. Johnston GC, Jockusch J, McMurtry LC, et al: Cytomegalovirus (CMV) titers among acquired immunodeficiency syndrome (AIDS) patients with and without a history of Kaposi's sarcoma (KS). Cancer Detect Prevent 14-337-342, 1990.
10. Drew WL, Mills J, Hauer LB, et al: Declining prevalence of Kaposi's sarcoma in homosexual AIDS patients paralleled by fall in cytomegalovirus transmission. Lancet 1:66, 1988
11. Andersen GB, Karkov J, Bjerregaard B, et al: Cytomegalovirus infection in classic endemic and epidemic Kaposi's sarcoma analyzed by in situ hybridization APMIS 99:893-897, 1991.
12. Rappersberger K. Tscachler E, Zonzits E. et al: Endemic Kaposi's sarcoma in HIV-1 seronegative persons: Demonstration of retrovirus like particles in cutaneous lesions J Invest Dermatol 95:371-381, 1990.
13. Huang YQ, Li JJ, Rush MG, et al: HPV-16 related DNA sequences in Kaposi's sarcoma. Lancet 339:515-518, 1992.
14. Chang Y, Cesarman E, Pessin MS, et al: Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994.
15. Moore PS, Chang Y: Detection of herpes virus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332:1181-1185, 1995
16. Huang YQ, Li JJ, Kaplan MH, et al: Human herpes virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345:759-761, 1995.
17. Dupin N, Grandadam M, Calvez V, et al: Herpes virus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345:761-762, 1995.
18. Cesarman E, Chang Y, Moore PS, et al: Kaposi's sarcoma-associated herpes virus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191, 1995.
19. Rady PL, Yen A, Rollefson JL, et al: Herpes virus-hke DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients Lancet 345:1339-1340, 1995.
20. Mitsuyasu RT: Kaposi's sarcoma in the acquired immunodeficiency syndrome. Infect Dis Clin North Am 2:511-523, 1989.
21. Gottlieb GJ, Ackerman AB: Kaposi's Sarcoma: A Text and Atlas. Philadelphia, Lea and Feiger, 1988.
22. Kaul A, Pearson JD, Petty R, et al: Vascular epithelium: A potential role in HIV infection and the pathogenesis of Kaposi's sarcoma. Mol Aspects Med 12:297-312, 1991.
23. Ensoli B, Barillari G, Gallo RC: Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am 5(2):281-295, 1991.
24. Weich HA, Salahuddin SZ, Gill P, et al: AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. Am J Pathol 139:1251-1258, 1991
25. Nakamura S, Salahuddin SZ, Biberfeld P, et al: Kaposi's sarcoma cells: Long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science 242:426-430, 1988.
26. Miles SA: Pathogenesis of HIV-related Kaposi's sarcoma. Curr Opin Oncol 6:497-502, 1994.
27. Salahuddin SZ, Nakamura S, Biberfeld P, et al: Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro Science 242:430-433, 1988.
28. Ensoli B, Salahuddin SZ, Gallo RC: AIDS-associated Kaposi's sarcoma: A molecular model for its pathogenesis. Cancer Cells 1:93-96, 1989.
29. Ensoli B, Barillari G, Gallo RC: Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 127:147-155, 1992.
30. Barillari G, Buonaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 149:3727-3734, 1992.
31. Roth WK: TGFβ and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Res Virol 144:105-109, 1993.
32. Miles SA: Kaposi's sarcoma, in Benz CC and Liu ET (eds): A cytokine responsive neoplasia, in Oncogenes and Tumor Suppressor Genes in Human Malignancies, pp 129-140. Boston, Kluwer Academic Publishers, 1993.
33. Nair BC, Devico AL, Nakamura S, et al: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255:1430-1432, 1992.
34. Miles SA, Martinez-Maza O, Rezai A, et al: Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432-1434, 1992.
35. Huang YQ, Li JJ, Kim KS, et al: HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro. AIDS 7:317-322, 1993.
36. Ensoli B, Nakamura S, Saluhuddin SZ, et al: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223-226, 1989.
37. Sturzl M, Willi KR, Brockmeyer NH, et al. Expression of PDGF and its receptor in AIDS-related KS in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA, 89,7046-7050, 1992.
38. Vogel J, Hinrichs SH, Reynolds RK, et al: The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611, 1988.
39. Ensoli B, Barillari G, Salahuddin SZ, et al: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients Nature 345.84-86, 1990.
40. Ensoli B, Buonaguro L, Barillari G, et al: Release and uptake, and effects of extracellular human immunodeficiency virus type I tat protein on cell growth and viral transactivation. J Virol 67:277-287, 1993.
41. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al: AIDS Kaposi's sarcoma-derived cells produce and respond to IL-6. Proc Natl Acad Sci USA 87:4068-4072, 1990.
42. Motro B, Itin A, Sachs L, et al: Pattern of interleukin-6 gene expression in vivo suggests a role of this cytokine in angiogenesis. Proc Natl Acad Sci USA 87:3092-3096, 1990.
43. Gearing DP, Comeau MR, Friend DJ, et al: The IL-6 signal transducer, gp130. An oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437, 1992.
44. Martinez-Maza O, Dourado I, Kishimoto T, et al: Elevated serum IL-6 levels are associated with the development of AIDS-KS (abstract). Ninth International Conference on AIDS, vol 1, p 397, 1993.
45. De Wit R, Raasveld MHM, Ten Berge RJM, et al: Il-6 concentrations in the serum of patients with AIDS-associated Kaposi's sarcoma during treatment with interferon alpha. J Intern Med 229:539-542, 1991.
46. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47:5155-5161, 1987.
47. Browning PJ, Roberts DD, Zabrenetsky V, et al. Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice. J Exp Med 180:1949-1954, 1994.
48. Sinkovics JG: Kaposi's sarcoma: Its "oncogenes" and growth factors. Crit Rev Oncol Hematol. 11:87-107, 1991.
49. Huang YQ, Li JJ, Moscatelli D, et al: Expression of Int-2 oncogene in KS lesions. J Clin Invest 91:1191-1197, 1993.
50. McGrath MS, Shiramizu BT, Hernider BG: Identification of a clonal form of HIV in early Kaposi's sarcoma: Evidence for a novel model of oncogenesis, "sequential neoplasia." J Acquir Immune Defic Syndr Hum Retrovirol 8:379-385, 1995.
51. Gill PS, Louriero C, Bernstein-Singer M, et al: Clinical effect of Glucocorticoids on Kaposi's sarcoma related to AIDS. Ann Intern Med 110:937-940, 1989.
52. Christeff N, Winter C, Gharakhanian S, et al: Androgens of HIV positive patients with or without Kaposi's sarcoma. J Clin Path, 48:513-518, 1995.
53. Corallini A, Altavilla G, Pozzi L, et al: Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 53:5569-5575, 1993.
54. Herndier BG, Werner A, Arnstein P, et al: Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 8:575-581, 1994.
55. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375: 64-68, 1995.
56. Harris PJ: Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. Lancet 346:118-119, 1995.